4.5 Review

From Pyridinium-based to Centrally Active Acetylcholinesterase Reactivators

Journal

MINI-REVIEWS IN MEDICINAL CHEMISTRY
Volume 14, Issue 3, Pages 215-221

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389557514666140219103138

Keywords

Acetylcholinesterase; HI-6; organophosphorus compounds; pyridinium oximes; pralidoxime; reactivator; trimedoxime; uncharged reactivator

Funding

  1. Grant Agency of the Ministry of Health [NT12062]
  2. Long Term Development plan - 1011
  3. MH CZ - DRO (University Hospital Hradec Kralove) [00179906]
  4. Ministry of Education, Youth and Sports [MSM0021620849]
  5. Charles University in Prague (Czech Republic) [PRVOUK-P26/LF1/4]
  6. Ministry of Education, Youth and Sports of the Czech Republic [SVV-267-001]
  7. [SV/FVZ201201]
  8. [SV/FVZ2011/04]
  9. [CZ.1.07/2.3.00/30.0044]

Ask authors/readers for more resources

Organophosphates are used as pesticides or misused as warfare nerve agents. Exposure to them can be fatal and death is usually caused by respiratory arrest. For almost six decades, pyridinium oximes represent a therapeutic tool used for the management of poisoning with organophosphorus (OP) compounds. However, these compounds possess several drawbacks. Firstly, they are inefficient in the restoration of brain acetylcholinesterase (AChE) activity due to a hard blood-brain barrier penetration. Secondly, there is no broad-spectrum AChE reactivator. Lastly, none of the oximes can reactivate aged AChE. In this context, uncharged reactivators represent a new hope in a way of increased bioavailability in the central compartment and better therapeutic management of the OP poisoning.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available